Skip to main content Back to Top
Advertisement

10/16/2024

Linezolid Injection

Products Affected - Description

    • Zyvox intravenous solution for injection, Pfizer, 2 mg/mL, 100 mL bag, 10 count, NDC 00009-5137-04
    • Zyvox intravenous solution for injection, Pfizer, 2 mg/mL, 300 mL bag, 10 count, NDC 00009-5140-04
    • Linezolid intravenous solution for injection, Eugia US, 2 mg/mL, 300 mL bag, 10 count, NDC 55150-0242-51
    • Linezolid intravenous solution for injection, Fresenius Kabi, 2 mg/mL, 300 mL bag, 10 count, NDC 63323-0713-13
    • Linezolid intravenous solution for injection, Hikma, 2 mg/mL, 300 mL bag, 10 count, NDC 00143-9534-10
    • Linezolid intravenous solution for injection, Pfizer, 2 mg/mL, 300 mL bag, 10 count, NDC 00409-4883-10
    • Linezolid intravenous solution for injection, Pfizer, 2 mg/mL, 300 mL VisIV bag, 10 count, NDC 00409-4883-01
    • Linezolid intravenous solution for injection, Sandoz, 2 mg/mL, 300 mL bag, 10 count, NDC 00781-3433-95

Reason for the Shortage

    • Eugia did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Pfizer states the shortage is due to manufacturing delays.
    • Piramal Critical Care has linezolid injection available.
    • Sandoz did not provide a reason for the shortage.
    • Sun Pharma has linezolid injection available.

Available Products

    • Linezolid intravenous solution for injection, Piramal Critical Care, 2 mg/mL, 300 mL bag, 10 count, NDC 66794-0219-43
    • Linezolid intravenous solution for injection, Sun Pharma, 2 mg/mL, 300 mL bag, 10 count, NDC 57664-0683-57

Estimated Resupply Dates

    • Eugia has linezolid 600 mg/300 mL bags on intermittent back order and the company is releasing supplies as they become available.
    • Fresenius Kabi has linezolid 600 mg/300 mL bags on back order and the company estimates a release date of late-January 2024.
    • Hikma has linezolid 600 mg/300 mL bags on back order and the company cannot estimate a release date.
    • Pfizer has linezolid 600 mg/300 mL VisIV bags on back order and the company estimates a release date of June 2025. Linezolid 600 mg/300 mL bags are on back order and the company estimates a release date of November 2024.
    • Pfizer has Zyvox 600 mg/300 mL bags on back order and the company estimates a release date of November 2024. Zyvox 200 mg/100 mL bags are also on back order and the company estimates a release date of June 2025.
    • Sandoz has linezolid 600 mg/300 mL bags on back order and the company cannot estimate a release date.

Updated

Created October 16, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT